Stay updated with breaking news from Sciences Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Silvant Capital Management LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 shares during the period. Silvant […]
Perfromance Wealth Partners LLC reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,737 shares of the medical research company’s stock after selling 565 shares during the period. […]
Rhenman & Partners Asset Management AB trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 8.6% in the third quarter, Holdings Channel.com reports. The firm owned 160,000 shares of the medical research company’s stock after selling 15,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Exact Sciences were […]
Biondo Investment Advisors LLC boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares during the […]
Swiss National Bank trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.8% during the third quarter, HoldingsChannel.com reports. The fund owned 580,280 shares of the medical research company’s stock after selling 63,200 shares during the quarter. Swiss National Bank’s holdings in Exact Sciences were worth $39,587,000 at the end of the […]